Factors influencing the length of hospital stay during the intensive phase of multidrug-resistant tuberculosis treatment at Amhara regional state hospitals, Ethiopia: a retrospective follow up study

被引:4
|
作者
Tamirat, Koku Sisay [1 ]
Andargie, Gashaw [2 ]
Babel, Yaregal Animut [1 ]
机构
[1] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, POB 196, Gondar, Ethiopia
[2] Univ Gondar, Inst Publ Hlth, Dept Hlth Serv Management & Hlth Econ, Coll Med & Hlth Sci, POB 196, Gondar, Ethiopia
关键词
Multidrug-resistant tuberculosis; Length of hospital stay; Ethiopia; MDR-TB; CARE; QUALITY; COSTS;
D O I
10.1186/s12889-020-09324-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe length of hospital stay is the duration of hospitalization, which reflects disease severity and resource utilization indirectly. Generally, tuberculosis is considered an ambulatory disease that could be treated at DOTs clinics; however, admission remains an essential component for patients' clinical stabilization. Hence, this study aimed to identify factors influencing hospital stay length during the intensive phase of multidrug-resistant tuberculosis treatment.MethodsA retrospective follow-up study was conducted at three hospitals, namely the University of Gondar comprehensive specialized, Borumeda, and Debremarkos referral hospitals from September 2010 to December 2016 (n=432). Data extracted from hospital admission/discharge logbooks and individual patient medical charts. A binary logistic regression analysis was used to identify factors associated with more extended hospital stays during the intensive phase of multidrug-resistant tuberculosis treatment.ResultMost patients (93.5%) had a pulmonary form of multidrug-resistant tuberculosis and 26.2% had /TB/HIV co-infections. The median length of hospital stays was 62 (interquartile range from 36 to 100) days. The pulmonary form of tuberculosis (Adjusted odds ratio [AOR], 3.47, 95% confidence interval [CI]; 1.31 to 9.16), bedridden functional status (AOR=2.88, 95%CI; 1.29 to 6.43), and adverse drug effects (AOR=2.11, 95%CI; 1.35 to 3.30) were factors associated with extended hospital stays.ConclusionThis study revealed that the length of hospital-stay differed significantly between the hospitals. The pulmonary form of tuberculosis decreased functional status at admission and reported adverse drug reactions were determinants of more extended hospital stays. These underscore the importance of early case detection and prompt treatment of adverse drug effects.
引用
收藏
页数:9
相关论文
共 24 条
  • [1] Factors influencing the length of hospital stay during the intensive phase of multidrug-resistant tuberculosis treatment at Amhara regional state hospitals, Ethiopia: a retrospective follow up study
    Koku Sisay Tamirat
    Gashaw Andargie
    Yaregal Animut Babel
    BMC Public Health, 20
  • [2] Survival status and risk factors for mortality among multidrug-resistant tuberculosis patients in Addis Ababa, Ethiopia: A retrospective follow-up study
    Getahun, Genanew Kassie
    Gezahegn, Elias
    Endazenawe, Getabalew
    Shitemaw, Tewodros
    Negash, Zelalem
    Dessu, Samuel
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2023, 33
  • [3] Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia: a retrospective follow-up study
    Kassa, Getahun Molla
    Tadesse, Abilo
    Gelaw, Yalemzewod Assefa
    Alemayehu, Temesgen Tadesse
    Tsegaye, Adino Tesfahun
    Tamirat, Koku Sisay
    Akalu, Temesgen Yihunie
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [4] Multidrug-resistant tuberculosis treatment outcomes and associated factors at Yirgalem General Hospital, Sidama Region, South Ethiopia: a retrospective cohort study
    Kebede, Assefa Hamato
    Mamo, Hassen
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [5] Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study
    Belachew, Teshome
    Yaheya, Seid
    Tilahun, Nehemia
    Gebrie, Eshet
    Seid, Rim
    Nega, Tilahun
    Biset, Sirak
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 2891 - 2899
  • [6] Treatment delay and associated factors among adults with drug resistant tuberculosis at treatment initiating centers in the Amhara regional state, Ethiopia
    Tefera, Kenaw Tegegne
    Mesfin, Nebiyu
    Reta, Mebratu Mitiku
    Sisay, Malede Mequanent
    Tamirat, Koku Sisay
    Akalu, Temesgen Yihunie
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [7] Rifampicin-Resistant Multidrug-Resistant Tuberculosis Cases in Selected Hospitals in Western Oromia, Ethiopia: Cross-Sectional Retrospective Study
    Zewdie, Olifan
    Dabsu, Regea
    Kifle, Edosa
    Befikadu, Dachasa
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 3699 - 3705
  • [8] Incidence and predictors of neonatal mortality among neonates admitted in Amhara regional state referral hospitals, Ethiopia: prospective follow up study
    Mengistu, Banchigizie Adane
    Yismaw, Ayenew Engida
    Azene, Zelalem Nigussie
    Mihret, Muhabaw Shumye
    BMC PEDIATRICS, 2020, 20 (01)
  • [9] Key factors influencing multidrug-resistant tuberculosis in patients under anti-tuberculosis treatment in two centres in Burundi: a mixed effect modelling study
    Iradukunda, Arnaud
    Ndayishimiye, Gabin-Pacifique
    Sinarinzi, Darlene
    Odjidja, Emmanuel Nene
    Ntakaburimvo, Nestor
    Nshimirimana, Innocent
    Izere, Cheilla
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [10] Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study
    Molie, Teklu
    Teklemariam, Zelalem
    Klinkenberg, Eveline
    Dessie, Yadeta
    Kumsa, Andargachew
    Mohammed, Hussen
    Debebe, Adisalem
    Assefa, Dawit
    Habte, Abebe
    Bedru, Ahmed
    Fiseha, Daniel
    Seyoum, Berhanu
    BMC INFECTIOUS DISEASES, 2019, 19 (01)